Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK's Karen Vousden to join BMS board

She will also serve on the pharma firm's Science and Technology Committee

Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm's Science and Technology Committee.

She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.

Giovanni Caforio, BMS’ chairman and chief executive officer, said: "Karen is a world class cancer researcher and a highly accomplished leader in her field.

“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”

18th September 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics